Osteoporosis Drug May Keep Type 2 Diabetes at Bay
TUESDAY, Sept. 28, 2021 (HealthDay News) — A drug widely used to treat osteoporosis might reduce the risk of type 2 diabetes, a new study suggests. Taking the drug alendronate (Fosamax) for at least eight years could potentially reduce a person’s risk of type 2 diabetes by more than half,Continue Reading